BAG3 and neoplasm: While a modest response was observed in mice treated with gemcitabine, a significant (P < 0.05) tumor growth inhibition was detected in BAG3‐H2L4‐treated mice (Fig. 3A). Of note, no significant weight loss was observed during the antibody treatment (data not shown).